Results

Total Results: 1,653 records

Showing results for "described".

441. Disposition of Comments Report for Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
     July 10, 2012 - Regarding the NIAAA recommendations, we revised our wording of the recommendations as described in … It may be useful to add some material along the lines described below, taking care not to obscure the … The type of training received was often described fairly briefly, possibly due to space limitations … Peer Reviewer #1 Results I am not sure that the tools should be described as commonly used. … We have re-written KQ2 as described in previous responses.

442. Options for Developing a Web-Based Forum on Patient Registries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
     May 01, 2014 - Stakeholders shared their perspectives on the need for a Web-based forum on patient registries and described … These and other features of the forum are described in more detail below, and the recommendations are … The technical features described below are known as Web 2.0 concepts; that is, “Web applications that … includes a Federal agency, consider the regulations to which the Web-based CoP will be subject, as described … The vendor should be template- and/or module- driven, as described above, and should offer the flexibility

443. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - All gaps described in Key Questions 2, 3, and 4 are applicable to this overarching question. … Criteria for Prioritization Stakeholders (described in the next section) were asked to consider four … All gaps described in Key Questions 2, 3, and 4 are applicable to this overarching question. … Criteria for Prioritization Stakeholders (described in the next section) were asked to consider four … generally accepted reference standard tests for determining iron deficiency in the setting of CKD (described

444. Methods-Balancing-Harms-Benefits Research-2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
     January 01, 2012 - The team also evaluated articles citing any of the above articles to determine whether they described … We described all quantitative approaches using the final list of key characteristics and unified the … As described earlier in this report, the Gail/NCI approach calculates a benefit and harm comparison … The decisions are parallel to those described in this report under ―evidence generation.‖ In the EPC … In Objective 2, we described the methodological characteristics of existing quantitative approaches

445. Schedule of Visits and Use of Telemedicine for Routine Antenatal Care: A Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
     January 01, 2020 - As described below, we will evaluate the strength of evidence (SoE) for these outcomes. … Qualitative studies (KQ 3) We will search for qualitative studies as part of the overall search described … extended into the grey literature (evidence from sources not identified using standard methods, as described … Each study will be described in summary and evidence tables presenting study design features, study

446. Venous-Ulcers-Treatment-Future Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
     January 01, 2014 - The stakeholders were asked to rank these from 1 (highest) to 3 (lowest), based on the criteria described … After determining a preliminary top-tier cutpoint according to the score sums as described above, we … After determining a preliminary top-tier cutpoint according to the score sums as described above, we … Such characteristics should be described for intervention and comparison groups to determine and adjust … All such events should be described in the articles that report the results of such studies.

447. Disposition of Comments Report for Medication Adherence Interventions: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_disposition-comments.pdf
     September 11, 2012 - Response Peer Reviewer #3 Results The results are thoroughly presented and the studies are very well described … Peer Reviewer #7 Discussion/ Conclusion The limitations of the review/studies are described adequately … In revising this report, the primary emphasis should be on improving its clarity and usability, as described … The well-described search strategy and comprehensive assessment of adherence interventions conducted

448. Disposition of Comments: Technical Brief 34, Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-34-health-worker-certification-comments.pdf
     March 27, 2020 - Once we have clearly described these goals at the outset of the report, the reader is better positioned … We would not characterize the grey literature documents as strongly in favor of certification; as described

449. EHC Research Protocol: Documentation Burden (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-protocol.pdf
     July 26, 2023 - definitions and metrics for documentation burden are lacking.10, 11 Documentation burden has been described … physician work experiences, and documentation burden for other healthcare professionals has not been described

450. Disposition of Comments for Technical Brief 24 Resident Safety Practices (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
     May 27, 2016 - teamwork across units, and management support for patient safety are safety dimension that have been described … Peer reviewer #1 Findings Table 8: 3rd row: 7 interventions described; results for only a few given … These are not about medication errors or even AEs This table reports on focus of interventions described … The report now focuses on primary safety issues; potential contributing factors are described as areas … The participation of Key Informants is well described. Thank you for your comment. 257.

451. Disposition of Comments for Technical Brief 27 Patient Safety (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
     October 19, 2016 - Medication safety is described as "doing no harm" or at times the somewhat more expanded view of " … No response needed KI Reviewer #5 Methods Details of the methodology are very well described and … more clear to readers what perspectives were represented KI Reviewer #5 Methods Key informants are described … KI Reviewer #2 Methods Literature scan is well described, as are the interviews with the KIs.

452. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - When alendronate was approved the method described in product labeling for identifying patients with … In the Executive Summary on page ES-6 and within Scope and Key Questions on page 6, denosumab is described … Chapell, Richard Executive Summary and Introduction -KQ 1 Zolendronate is described as "oral … Peer Reviewer 1 Methods: Chapter 2 Excellent and well described No response needed. … One study is described as "written by the makers of riesedronate", while another is simply described

453. Disposition of Comment Report for Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
     May 20, 2013 - As described in my comments under b) above, this has significant problems. … These distinctions are described in the methods. … These distinctions are described in the methods. … These distinctions are described in the methods. … Yes, thank you, we described this in our limitations and in our results.

454. Cover Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
     September 01, 2007 - this section, we give a brief overview of the Drug Effectiveness Reporting and Monitoring System described … The concept demonstration prototype described in this paper mitigates some of the problems, but several

455. Cover Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
     September 01, 2007 - this section, we give a brief overview of the Drug Effectiveness Reporting and Monitoring System described … The concept demonstration prototype described in this paper mitigates some of the problems, but several

456. Prostate-Cancer-Test Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
     April 01, 2013 - The Key Questions (KQs) relate to the three proposed scenarios described above: KQ1: In patients with … KQ 1 and 2: Initial and Repeat Biopsies In addition to the 9 studies described above, another 15 studies … provided sufficient data to compare the diagnostic accuracy of PCA3 with tPSA elevations, using the five described … Performance of PCA3 and comparators in a broader range of health care settings may differ from that described

457. Undescended-Testicle Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
     December 01, 2012 - If a study had negative imaging for all subjects, if the imaging techniques were not adequately described … We used the approach to strength of evidence assessment described in the Effective Health Care Program … Only four studies adequately described selection criteria for the participants, and three studies provided … surgical approach was assessed independently for ability to achieve testicular descent because, as described

458. Medical Therapies for Children With Autism Spectrum Disorder—An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
     May 01, 2017 - Dietary and nutritional studies included some younger children, with severity of autism not well described … Studies also typically described interventions fully, used standardized diagnostic processes and blinded … Harms reporting varied across studies; some studies amply described how harms were tracked, while others … Harms reporting varied across studies; some studies amply described how harms were tracked, while others

459. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
     November 27, 2012 - We have further described “mimic” conditions. … We included studies if they reported our described outcomes of interest even if IRLS scores were not … Primary outcomes were determined by us, discussed with our TEP and described in our protocol. … & Affiliation Section Comment Response Peer Reviewer #6 Results The detail of the results as described

460. Assessing the Impact of Indexing Performance Measure Codes on the Perceived Value of EPC Reports to Health Systems (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-assessing-impact.pdf
     September 01, 2018 - Health-System Representative 2 12 min 3 min 11 min 5 min Note: While the participants are described … As described above, these responses informed improvements in the quality measure index before we began … In the phase two assessment, we used the two exercise scenarios and three query questions described … Health-System Representative 2 12 min 3 min 11 min 5 min Note: While the participants are described